Genome-wide association study of classical hodgkin lymphoma and epstein-barr virus status-defined subgroups

Journal of the National Cancer Institute

Volumn 104, Issue 3, 2012, Pages 240-253

  Urayama, Kevin Y ^a   Jarrett, Ruth F ^b   Hjalgrim, Henrik ^c   Diepstra, Arjan ^d   Kamatani, Yoichiro ^e   Chabrier, Amelie ^a   Gaborieau, Valerie ^a   Boland, Anne ^f   Nieters, Alexandra ^g   Becker, Nikolaus ^h   Foretova, Lenka ⁱ   Benavente, Yolanda ^j,k   Maynadié, Marc ^l   Staines, Anthony ^m   Shield, Lesley ^b   Lake, Annette ^b   Montgomery, Dorothy ^b   Taylor, Malcolm ⁿ   Smedby, Karin Ekström ^o   Amini, Rose Marie ^p   Adami, Hans Olov ^q,r   Glimelius, Bengt ^p   Feenstra, Bjarke ^c   Nolte, Ilja M ^d   Visser, Lydia ^d   Van Imhoff, Gustaaf W ^d   Lightfoot, Tracy ^s   Cocco, Pierluigi ^t   Kiemeney, Lambertus ^u   Vermeulen, Sita H ^u   Holcatova, Ivana ^v   Vatten, Lars ^w   MacFarlane, Gary J ^x   Thomson, Peter ^y   Conway, David I ^z   Benhamou, Simone ^aa   Agudo, Antonio ^ab   Healy, Claire M ^ac   Overvad, Kim ^ad   Tjønneland, Anne ^ae   Melin, Beatrice ^af   Canzian, Federico ^h   Khaw, Kay Tee ^ag   Travis, Ruth C ^ah   Peeters, Petra H M ^ai   González, Carlos A ^ab   Quirós, José Ramón ^aj   Sánchez, María José ^k,ak   Huerta, José María ^k,al   Ardanaz, Eva ^k,am   Dorronsoro, Miren ^k,an   Clavel Chapelon, Fraçoise ^ao   Bueno De Mesquita, H Bas ^ai,ap   Riboli, Elio ^aq   Roman, Eve ^s   Boffetta, Paolo ^ar,as   De Sanjosé, Silvia ^j,k   Zelenika, Diana ^f   Melbye, Mads ^c   Van Den Berg, Anke ^d   Lathrop, Mark ^e,f   Brennan, Paul ^a   McKay, James D ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

^c STATENS SERUM INSTITUT   (Denmark)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e FONDATION JEAN DAUSSET CEPH   (France)

^f CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^g UNIVERSITY OF FREIBURG   (Germany)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁱ MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^j CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^k CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^l UNIVERSITÉ DE BOURGOGNE   (France)

^m DUBLIN CITY UNIVERSITY   (Ireland)

ⁿ UNIVERSITY OF MANCHESTER   (United Kingdom)

^o KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^p UPPSALA UNIVERSITY   (Sweden)

^q KAROLINSKA INSTITUTE   (Sweden)

^r HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^s UNIVERSITY OF YORK   (United Kingdom)

^t UNIVERSITY OF CAGLIARI   (Italy)

^u RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^v CHARLES UNIVERSITY   (Czech Republic)

^w NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^x UNIVERSITY OF ABERDEEN   (United Kingdom)

^y NEWCASTLE UNIVERSITY   (United Kingdom)

^z UNIVERSITY OF GLASGOW   (United Kingdom)

^aa INSERM   (France)

^ab BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^ac TRINITY COLLEGE DUBLIN   (Ireland)

^ad AARHUS UNIVERSITY   (Denmark)

^ae INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^af UMEÅ UNIVERSITY   (Sweden)

^ag UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ah UNIVERSITY OF OXFORD   (United Kingdom)

^ai UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^aj Asturian Council for Health and Health Care   (Spain)

^ak ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^al Murcia Regional Health Authority   (Spain)

^am INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^an Public Health Division of Gipuzkoa   (Spain)

^ao INSTITUT GUSTAVE ROUSSY   (France)

^ap NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^aq IMPERIAL COLLEGE LONDON   (United Kingdom)

^ar MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^as INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE PROTEIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN ERAP1; PROTEIN HCG9; PROTEIN MICB; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLASSICAL HODGKIN LYMPHOMA; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NODULAR SCLEROSIS HODGKIN LYMPHOMA; PRIORITY JOURNAL; PSORIASIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINOPEPTIDASES; EPSTEIN-BARR VIRUS INFECTIONS; GENOME-WIDE ASSOCIATION STUDY; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-DR ALPHA-CHAINS; HODGKIN DISEASE; HUMANS; LOGISTIC MODELS; ODDS RATIO; RISK FACTORS;

EID: 84856845730     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr516     Document Type: Article

References (58)

1. Curado MP, Edwards B, Shin HR, et al. Cancer Incidence in Five Continents. Volume IX. Lyon, France: IARC Scientific Publications; 2007.
2. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.
3. Kuppers R. The biology of Hodgkin's lymphoma. Nat Rev Cancer. 2009;9(1):15-27.
4. International Agency for Research on Cancer (IARC). Epstein-Barr virus and Kaposi's sarcoma Herpesvirus/Human Herpesvirus 8. IARC Monogr Eval Carcinog Risks Hum. 1997;70:1-492.
5. Gulley ML, Eagan PA, Quintanilla-Martinez L, et al. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity. Blood. 1994;83(6):1595-1602. (Pubitemid 24081574)
6. Jarrett RF, Krajewski AS, Angus B, et al. The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates. J Clin Pathol. 2003;56(11):811-816. (Pubitemid 37386566)
7. Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer. 1997;70(4):375-382. (Pubitemid 27107262)
8. Diepstra A, Niens M, Vellenga E, et al. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus- negative Hodgkin's lymphoma. Lancet. 2005;365(9478):2216-2224. (Pubitemid 40853915)
9. Hjalgrim H, Rostgaard K, Johnson PC, et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma. Proc Natl Acad Sci USA. 2010;107(14):6400-6405.
10. Niens M, Jarrett RF, Hepkema B, et al. HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma. Blood. 2007;110(9):3310-3315. (Pubitemid 350106324)
11. Enciso-Mora V, Broderick P, Ma Y, et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet. 2010;42(12):1126-1130.
12. Besson H, Brennan P, Becker N, et al. Tobacco smoking, alcohol drinking and Hodgkin's lymphoma: a European multi-centre case-control study (EPILYMPH). Br J Cancer. 2006;95(3):378-384. (Pubitemid 44187602)
13. Alexander FE, Lawrence DJ, Freeland J, et al. An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): evidence for a specific association with EBV+ve HD in young adults. Int J Cancer. 2003;107(2):298-302. (Pubitemid 37152914)
14. Smedby KE, Hjalgrim H, Melbye M, et al. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst. 2005;97(3):199-209. (Pubitemid 40277370)
15. Lagiou P, Georgila C, Minaki P, et al. Alcohol-related cancers and genetic susceptibility in Europe: the ARCAGE project: study samples and data collection. Eur J Cancer Prev. 2009;18(1):76-84.
16. Hashibe M, McKay JD, Curado MP, et al. Multiple ADH genes are associated with upper aerodigestive cancers. Nat Genet. 2008;40(6):707-709. (Pubitemid 351748869)
17. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41(9):986-990.
18. Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M. Age-and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int. 2007;72(5):632-637. (Pubitemid 47312796)
19. Holmen TL, Barrett-Connor E, Holmen J, Bjermer L. Health problems in teenage daily smokers versus nonsmokers, Norway, 1995-1997: the Nord-Trondelag Health Study. Am J Epidemiol. 2000;151(2):148-155. (Pubitemid 30463645)
20. Kronborg J, Jenssen T, Njolstad I, Toft I, Eriksen BO. Metabolic risk factors associated with serum creatinine in a non-diabetic population. Eur J Epidemiol. 2007;22(10):707-713. (Pubitemid 47476678)
21. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447(7145):661-678.
22. Purdue MP, Johansson M, Zelenika D, et al. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet. 2011;43(1):60-65.
23. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575. (Pubitemid 47330214)
24. Yu K, Wang Z, Li Q, et al. Population substructure and control selection in genome-wide association studies. PLoS One. 2008;3(7):e2551.
25. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904-909. (Pubitemid 44141658)
26. Willett EV, O'Connor S, Smith AG, Roman E. Does smoking or alcohol modify the risk of Epstein-Barr virus-positive or-negative Hodgkin lymphoma? Epidemiology. 2007;18(1):130-136. (Pubitemid 46005917)
27. Hindorff LA, Junkins HA, Hall PN, Mehta JP, Manolio TA. A Catalog of Published Genome-Wide Association Studies. www.genome.gov/gwastudies. Accessed March 29, 2011.
28. Li X, Howard TD, Zheng SL, et al. Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. J Allergy Clin Immunol. 2010;125(2):328-335 e311.
29. Moffatt MF, Gut IG, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363(13):1211-1221.
30. Nair RP, Duffin KC, Helms C, et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41(2):199-204.
31. Strange A, Capon F, Spencer CC, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet. 2010;42(11):985-990.
32. Armstrong AA, Alexander FE, Cartwright R, et al. Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis. Leukemia. 1998;12(8):1272-1276. (Pubitemid 28395991)
33. Hjalgrim H, Smedby KE, Rostgaard K, et al. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res. 2007;67(5):2382-2388. (Pubitemid 46424260)
34. Maggio EM, Stekelenburg E, Van den Berg A, Poppema S. TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus. Int J Cancer. 2001;94(1):60-66. (Pubitemid 32801753)
35. Gulley ML, Glaser SL, Craig FE, et al. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J Clin Pathol. 2002;117(2):259-267. (Pubitemid 34823667)
36. Wang D, Sun Y, Stang P, Berlin JA, Wilcox MA, Li Q. Comparison of methods for correcting population stratification in a genome-wide association study of rheumatoid arthritis: principal-component analysis versus multidimensional scaling. BMC Proc. 2009;3(suppl 7):S109.
37. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG, eds. Systematic Reviews in Health Care: Meta-analysis in Context. London, UK: BMJ Publishing Group; 2001:285-312.
38. SAS Institute. SAS Statistical Software Version 9. Cary, NC: SAS Institute; 2004.
39. de Bakker PI, Ferreira MA, Jia X, Neale BM, Raychaudhuri S, Voight BF. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet. 2008;17(R2):R122-R128.
40. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA. 1994;91(14):6259-6263. (Pubitemid 24200639)
41. Klitz W, Aldrich CL, Fildes N, Horning SJ, Begovich AB. Localization of predisposition to Hodgkin disease in the HLA class II region. Am J Hum Genet. 1994;54(3):497-505. (Pubitemid 24068231)
42. Oza AM, Tonks S, Lim J, Fleetwood MA, Lister TA, Bodmer JG. A clinical and epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's disease. Cancer Res. 1994;54(19):5101-5105. (Pubitemid 24313484)
43. Taylor GM, Gokhale DA. Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype associated: response to Dorak, Mills, Poynton and Burnett. Leukemia. 1996;10(11):1850-1851.
44. Taylor GM, Gokhale DA, Crowther D, et al. Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes. Br J Cancer. 1999;80(9):1405-1411. (Pubitemid 29308610)
45. Vladich FD, Brazille SM, Stern D, Peck ML, Ghittoni R, Vercelli D. IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation. J Clin Invest. 2005;115(3):747-754. (Pubitemid 40322251)
46. Graves PE, Kabesch M, Halonen M, et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol. 2000;105(3):506-513. (Pubitemid 30169909)
47. He JQ, Chan-Yeung M, Becker AB, et al. Genetic variants of the IL13 and IL4 genes and atopic diseases in at-risk children. Genes Immun. 2003;4(5):385-389. (Pubitemid 38961147)
48. Skinnider BF, Elia AJ, Gascoyne RD, et al. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood. 2001;97(1):250-255. (Pubitemid 32061267)
49. Skinnider BF, Mak TW. The role of cytokines in classical Hodgkin lymphoma. Blood. 2002;99(12):4283-4297. (Pubitemid 34627193)
50. Ho IC, Tai TS, Pai SY. GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat Rev Immunol. 2009;9(2):125-135.
51. Stanelle J, Doring C, Hansmann ML, Kuppers R. Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells. Blood. 2010;116(20):4202-4211.
52. Monroy CM, Cortes AC, Lopez MS, et al. Hodgkin disease risk: role of genetic polymorphisms and gene-gene interactions in inflammation pathway genes. Mol Carcinog. 2011;50(1):36-46.
53. Kraft P. Curses-winner's and otherwise-in genetic epidemiology. Epidemiology. 2008;19(5):649-651; discussion 657-648.
54. Saveanu L, Carroll O, Lindo V, et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol. 2005;6(7):689-697. (Pubitemid 41716742)
55. Fruci D, Ferracuti S, Limongi MZ, et al. Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines. J Immunol. 2006;176(8):4869-4879.
56. Landgren O, Engels EA, Pfeiffer RM, et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst. 2006;98(18):1321-1330. (Pubitemid 44530727)
57. Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB. The risk of lymphoma in patients with psoriasis. J Invest Dermatol. 2006;126(10):2194- 2201. (Pubitemid 44413165)
58. Dommasch E, Gelfand JM. Is there truly a risk of lymphoma from biologic therapies? Dermatol Ther. 2009;22(5):418-430.